Article (Published version) (459 Kb) - 
Free access
Appendix (30 Kb) - Free access Appendix (25 Kb) - Free access Appendix (30 Kb) - Free accessOther version: https://www.sciencedirect.com/science/article/pii/S0163834321000268
Highlights
Scientific Article - Review
unige:150324 
 |
Toxicity of psychotropic drugs in patients with COVID-19: A systematic review |
|
| Authors | ||
| Published in | General hospital psychiatry. 2021, vol. 70, p. 1-9 | |
| Abstract | Due to the global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), guidance for the use of psychotropic drugs in this context is necessary. We aimed to review clinical evidence regarding the potential toxicity of psychiatric medications in the context of SARS-CoV-2 infection. | |
| Keywords | SARS-CoV-2 — COVID-19 — Toxicity — Psychotropic drugs — Clozapine — Lithium — Valproic acid | |
| Identifiers | PMID: 33631694 | |
| Full text |
Article (Published version) (459 Kb) - Free access Appendix (30 Kb) - Free access Appendix (25 Kb) - Free access Appendix (30 Kb) - Free access Other version: https://www.sciencedirect.com/science/article/pii/S0163834321000268 |
|
| Structures | ||
| Research group | Psychopathologie clinique et expérimentale (987) | |
| Citation (ISO format) | SABE, Michel et al. Toxicity of psychotropic drugs in patients with COVID-19: A systematic review. In: General Hospital Psychiatry, 2021, vol. 70, p. 1-9. doi: 10.1016/j.genhosppsych.2021.02.006 https://archive-ouverte.unige.ch/unige:150324 |
121 hits 
97 downloads 
Contact an author
Update